CDKN1B and neoplasm: It is known that miR-221 downregulates expression of some genes with tumor-suppressing function in melanoma, e.g., cyclin-dependent kinase inhibitor 1B (CDKN1B/p27Kip1), and c-KIT receptor (CD117) [16].